SCHEMBL470395

SCHEMBL470395

COc1ccccc1-c1noc(C)c1C(=O)N1CCN(c2cc(NC(=O)c3ccc(N4CC(=O)NC4=O)cc3)c(N=O)cc2Cl)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.52
MAPK1 P28482 1/20 0.52
LMNA P02545 5/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 1/20 0.44
HTT P42858 1/20 0.43
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
NPSR1 Q6W5P4 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.38
EPAS1 Q99814 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL470469 0.89 TSHR (0.52) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL16374973 0.89 TSHR (0.51) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL16374952 0.89 TSHR (0.51) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL10087686 0.86 TSHR (0.56) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL12523352 0.85 TSHR (0.54) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL12457258 0.83 TSHR (0.49) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL470304 0.79 TSHR (0.51) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL470242 0.79 TSHR (0.49) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL457864 0.78 TSHR (0.55) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL10087685 0.78 TSHR (0.55) TSHRMAPK1LMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033736-A1 NOVEL PIPERAZINE ANALOGS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed